Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections
Author:
Publisher
Informa Healthcare
Subject
Pharmacology,Toxicology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425250903145251
Reference111 articles.
1. Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2. Beta-Lactamase Inhibitors: Another Approach to Overcoming Antimicrobial Resistance
3. β-Lactamases and β-lactamase inhibitors
4. Comparative Inhibition of β-Lactamases by Novel β-Lactam Compounds
5. Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute Infection
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Re‐Imagining Drug Discovery using Mass Spectrometry;Israel Journal of Chemistry;2023-03-20
2. The clinical and paraclinical effectiveness of four-hour infusion vs. half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: An assessor-blinded randomized clinical trial;Journal of Critical Care;2023-02
3. HPTLC/MS and HPTLC/UV for monitoring of degradation behavior of some β-Lactam antibiotics mixtures under ambient storage conditions;Microchemical Journal;2023-02
4. Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass;Journal of Chemotherapy;2023-01-30
5. Biochemical exploration of β-lactamase inhibitors;Frontiers in Genetics;2023-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3